Real world safety of CT-P10 (anti-CD 20 monoclonal antibodies biosimilar) in rheumatic and autoimmune diseases

Katchamart, W; Ngamjanyaporn, P; Orawongpaisarn, A; Phubangkertphon, T; Borrirukwisitsak, S; Dechapaphapitak, N

Katchamart, W (通讯作者)，Mahidol Univ, Siriraj Hosp, Dept Med, Div Rheumatol,Fac Med, 2 Wanglang Rd, Bangkoknoi, Bangkok 10700, Thailand.

BMC RHEUMATOLOGY, 2022; 6 (1):

Abstract

Background: Rituximab (RTX), anti-CD 20 monoclonal antibodies, has been approved for many rheumatic and autoimmune diseases, the use of RTX is still l......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索